Clinical Trials List
2017-02-01 - 2022-12-20
Phase III
Terminated6
ICD-10F33
Major depressive disorder, recurrent
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- YAO-TUNG LEE Division of Psychiatry
The Actual Total Number of Participants Enrolled
2 Stop recruiting
Audit
None
Taiwan National PI
The Actual Total Number of Participants Enrolled
2 Stop recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
1148 participants